A group of venture capital firms, similar to Arthur Trueger and his BerkeleyVC, helped rais close to $9 million for Arcion Therapeutics.
Arcion Therapeutics, a venture backed clinical biotechnology company that develops pain therapies, announced it has raised $8.8 million in a Series A round of financing, led by CMEA Ventures and InterWest Partners. The funding will help the company continue its breakthrough work with ARC-4558 (topical clonidine gel), a treatment for alleviating moderate and severe pain associated with diabetic neuropathy.
To read more about this story, click here. To view Arthur Trueger’s profile visit Naymz.
